1. González, A., Schelbert, E. B., Díez, J. & Butler, J. Myocardial interstitial fbrosis in heart failure: Biological and translational perspectives. J. Am. Coll. Cardiol. 71, 1696–1706 (2018).
2. Frangoginnis, N. G. Cardiac fbrosis. Cardiovasc. Res. 117, 1450–1488 (2021).
3. Wada, A., Tsutamoto, T., Matsuda, Y. & Kinoshita, M. Cardiorenal and neurohumonal efects of endogeneous atrial natriuretic peptides in dog with severe congestive heart failure using a specifc antagonist for guanylate cyclase coupled receptor. Circulation 89, 2232–2240 (1994).
4. Wada, A. et al. Efects of a endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: Comparison of efects with those of endothelin a receptor antagonism. Circulation 99, 570–577 (1999).
5. Fujii, M. et al. Bradykinin improves lef ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure. Hypertension 39, 952–957 (2002).
6. Matsumoto, T. et al. Chymase inhibition prevents cardiac fbrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 107, 2555–2558 (2003).
7. Dohke, T. et al. Proteomic analysis reveals signifcant alternations of cardiac small heat shock protein expression in congestive heart failure. J. Cardiac. Failure 12, 77–84 (2006).
8. Isono, T., Matsumoto, T. & Wada, A. A global transcriptome analysis of a dog model of congestive heart failure with the human genome as a reference. J. Cardiac Failure 18, 872–878 (2012).
9. Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523. https://doi.org/10.1038/s41467-019-09234-6 (2019).
10. Markolovic, S., Wilkins, S. E. & Schofeld, C. J. Protein hydroxylation catalyzed by 2-oxoglutarate-dependent oxygenases. J. Biol. Chem. 290, 20712–20722 (2011).
11. Liguori, T. T. A., Liguori, G. R., Moreira, L. F. P. & Harmsen, M. C. Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced diferentiation of human cardiac fbroblasts into myofbroblasts. Sci. Rep. 8, 16633. https://doi.org/10.1038/s41598-018-34747-3 (2018).
12. Nomura, S. et al. Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure. Nat. Commun. 9, 4435. https://doi.org/10.1038/s41467-018-06639-7 (2018).
13. Vallet, S. D. & Ricard-Blum, S. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. Essays Biochem. 63, 349–364 (2019).
14. Sulser, P. et al. HIF hydroxylase inhibitors decrease cellular oxygen consumption depending on their selectivity. FASEB J. 34, 464–470 (2020).
15. Kiriakidis, S. et al. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to of-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor. Kidney Int. 92, 900–908 (2017).
16. Fu, X. et al. Specialized fbroblast diferentiated states underlie scar formation in the infarcted mouse heart. J. Clin. Invest. 128, 2127–2143 (2018).
17. Tallquist, M. D. & Molkentin, J. D. Redefning the identity of cardiac fbroblasts. Nat. Rev. Cardiol. 14, 484–491 (2017).
18. Martin, M. Cutadapt removes adapter sequences from high through put sequencing reads. EMB Net. J. 17, 10–12 (2011).
19. Kim, D. et al. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36. https://doi.org/10.1186/gb-2013-14-4-r36 (2013).
20. Trapnell, C. et al. Transcript assembly and quantifcation by RNA-Seq reveals unannotated transcripts and isoform switching during cell diferentiation. Nat. Biotech. 28, 511–515 (2010).
21. Wu, M. et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. 292, C125–C136 (2007).
22. Isono, T., Chano, T., Yonese, J. & Yuasa, T. Terapeutic inhibition of mitochondrial function induces cell death in starvationresistant renal cell carcinomas. Sci. Rep. 6, e25669. https://doi.org/10.1038/srep25669 (2016).